144 related articles for article (PubMed ID: 27846420)
1. Correlation of Tc17 cells at early stages after allogeneic hematopoietic stem cell transplantation with acute graft-versus-host disease.
Wang L; Zhao P; Song L; Yan F; Shi C; Li Y; Han M; Lan K
Int Immunopharmacol; 2016 Dec; 41():122-126. PubMed ID: 27846420
[TBL] [Abstract][Full Text] [Related]
2. The expression of Th17-associated cytokines in human acute graft-versus-host disease.
Liu Y; Cai Y; Dai L; Chen G; Ma X; Wang Y; Xu T; Jin S; Wu X; Qiu H; Tang X; Li C; Sun A; Wu D; Liu H
Biol Blood Marrow Transplant; 2013 Oct; 19(10):1421-9. PubMed ID: 23792271
[TBL] [Abstract][Full Text] [Related]
3. IL-17-producing T cells contribute to acute graft-versus-host disease in patients undergoing unmanipulated blood and marrow transplantation.
Zhao XY; Xu LL; Lu SY; Huang XJ
Eur J Immunol; 2011 Feb; 41(2):514-26. PubMed ID: 21268020
[TBL] [Abstract][Full Text] [Related]
4. [Reconstitution kinetics of T helper cells subsets post unmanipulated allogeneic blood and marrow transplantation].
Zhao XY; Zhao XS; Wang YZ; Chang YJ; Lv M; Wang HT; Han TT; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2013 Sep; 34(9):745-50. PubMed ID: 24103870
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between CD4(+)CD25(+) regulatory T cells, IL-2, TGF-beta and acute graft-versus host disease after allogeneic hematopoietic stem cell transplantation].
Niu YY; Ma LM; Zhou Y; Ren RR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):735-9. PubMed ID: 20561440
[TBL] [Abstract][Full Text] [Related]
6. Reconstitution and clinical significance of T cell subsets in the early stage after related HLA-mismatched peripheral blood hematopoietic SCT without T-cell depletion in vitro.
Pang N; Duan X; Jiang M; Qu J; Yuan H; Xu J; Cao H; Chen G
Int J Clin Exp Pathol; 2015; 8(8):8892-901. PubMed ID: 26464630
[TBL] [Abstract][Full Text] [Related]
7. Intestinal Microbiota at Engraftment Influence Acute Graft-Versus-Host Disease
Han L; Jin H; Zhou L; Zhang X; Fan Z; Dai M; Lin Q; Huang F; Xuan L; Zhang H; Liu Q
Front Immunol; 2018; 9():669. PubMed ID: 29740427
[TBL] [Abstract][Full Text] [Related]
8. Role of CD8 Regulatory T Cells versus Tc1 and Tc17 Cells in the Development of Human Graft-versus-Host Disease.
Gutiérrez-Hoya A; López-Santiago R; Vela-Ojeda J; Montiel-Cervantes L; Rodríguez-Cortés O; Rosales-García V; Paredes-Cervantes V; Flores-Mejía R; Sandoval-Borrego D; Moreno-Lafont M
J Immunol Res; 2017; 2017():1236219. PubMed ID: 28164135
[TBL] [Abstract][Full Text] [Related]
9. [The role of CD4+ CD25+ T cell and FOXP3 in hsot acute graft rejection].
Liu YJ; Wu DP; Li CX; He J; Qiu QC; Zhang XG
Zhonghua Nei Ke Za Zhi; 2006 Oct; 45(10):835-8. PubMed ID: 17217750
[TBL] [Abstract][Full Text] [Related]
10. Reconstitution of Th17, Tc17 and Treg cells after paediatric haematopoietic stem cell transplantation: Impact of interleukin-7.
Kielsen K; Ryder LP; Lennox-Hvenekilde D; Gad M; Nielsen CH; Heilmann C; Ifversen M; Pedersen AE; Müller K
Immunobiology; 2018 Feb; 223(2):220-226. PubMed ID: 29033080
[TBL] [Abstract][Full Text] [Related]
11. ADAR1 improved Treg cell function through the miR-21b/Foxp3 axis and inhibits the progression of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Zhao Y; Zheng X; Li M; Zhao J; Wang X; Zhu H
Int Immunopharmacol; 2023 Feb; 115():109620. PubMed ID: 36577155
[TBL] [Abstract][Full Text] [Related]
12. T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor.
Jiang H; Fu D; Bidgoli A; Paczesny S
Front Immunol; 2021; 12():761448. PubMed ID: 34675938
[TBL] [Abstract][Full Text] [Related]
13. Dynamic regulation of effector IFN-γ-producing and IL-17-producing T cell subsets in the development of acute graft-versus-host disease.
Zhao K; Ruan S; Yin L; Zhao D; Chen C; Pan B; Zeng L; Li Z; Xu K
Mol Med Rep; 2016 Feb; 13(2):1395-403. PubMed ID: 26647759
[TBL] [Abstract][Full Text] [Related]
14. IL-10 promoter polymorphisms influence susceptibility to aGvHD and are associated with proportions of CD4+FoxP3+ lymphocytes in blood after hematopoietic stem cell transplantation.
Jaskula E; Lange A; Dlubek D; Kyrcz-Krzemień S; Markiewicz M; Dzierzak-Mietla M; Jedrzejczak WW; Gronkowska A; Nowak J; Warzocha K; Hellmann A; Kowalczyk J; Drabko K; Goździk J; Mizia S;
Tissue Antigens; 2013 Dec; 82(6):387-96. PubMed ID: 24498995
[TBL] [Abstract][Full Text] [Related]
15. Impact of very early CD4(+) /CD8(+) T cell counts on the occurrence of acute graft-versus-host disease and NK cell counts on outcome after pediatric allogeneic hematopoietic stem cell transplantation.
Huttunen P; Taskinen M; Siitonen S; Saarinen-Pihkala UM
Pediatr Blood Cancer; 2015 Mar; 62(3):522-8. PubMed ID: 25417898
[TBL] [Abstract][Full Text] [Related]
16. IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effect.
Couturier M; Lamarthée B; Arbez J; Renauld JC; Bossard C; Malard F; Bonnefoy F; Mohty M; Perruche S; Tiberghien P; Saas P; Gaugler B
Leukemia; 2013 Jul; 27(7):1527-37. PubMed ID: 23399894
[TBL] [Abstract][Full Text] [Related]
17. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
[TBL] [Abstract][Full Text] [Related]
18. PIAS3 suppresses acute graft-versus-host disease by modulating effector T and B cell subsets through inhibition of STAT3 activation.
Lee SH; Moon SJ; Park MJ; Kim EK; Moon YM; Cho ML
Immunol Lett; 2014 Jul; 160(1):79-88. PubMed ID: 24718277
[TBL] [Abstract][Full Text] [Related]
19. Role of HMGB1 in regulation of STAT3 expression in CD4(+) T cells from patients with aGVHD after allogeneic hematopoietic stem cell transplantation.
Xu YJ; Li L; Chen Y; Fu B; Wu DS; Li XL; Zhao XL; Chen FP
Clin Immunol; 2015 Dec; 161(2):278-83. PubMed ID: 26327693
[TBL] [Abstract][Full Text] [Related]
20. Galectin-9 alleviates acute graft-versus-host disease after haplo-hematopoietic stem cell transplantation by regulating regulatory T cell/effector T cell imbalance.
Pang N; Tudahong S; Zhu Y; He J; Han C; Chen G; Wang W; Wang J; Ding J
Immun Inflamm Dis; 2024 Feb; 12(2):e1177. PubMed ID: 38353382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
